Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis

被引:64
作者
Hillier, T. A.
Rousseau, A.
Lange, C.
Lepinay, P.
Cailleau, M.
Novak, M.
Calliez, E.
Ducimetiere, P.
Balkau, B.
机构
[1] INSERM, Natl Hlth & Med Res Inst, U258, IFR69, F-94807 Villejuif, France
[2] Univ Paris S, Fac Med, Villejuif, France
[3] Kaiser Permanente, Ctr Hlth Res NW Hawaii, Portland, OR USA
[4] Hlth Examinat Ctr, Orleans, France
[5] Inter Reg Hlth Inst, DESIR Study, La Riche, France
[6] IRSA, Hlth Examinat Ctr, Chateauroux, France
[7] IRSA, Hlth Examinat Ctr, Angers, France
关键词
cardiovascular disease; incidence; metabolic syndrome; principal components analysis; syndrome X; type 2 diabetes mellitus;
D O I
10.1007/s00125-006-0266-8
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims/hypothesis: We devised a practical continuous score to assess the metabolic syndrome, and assessed whether this syndrome score predicts incident diabetes and cardiovascular disease. Subjects and methods: Among 5,024 participants of the Data from an Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.) cohort, we defined a metabolic syndrome score by the first principal component (PC1), using only the correlations between continuous metabolic syndrome measures (glucose, waist circumference, triglycerides, and systolic blood pressure). This metabolic syndrome score was highly correlated with a similar score also including insulin and HDL cholesterol (r (s) =0.94). Over 9 years of follow-up, incident diabetes and cardiovascular disease (CVD) were predicted by logistic regression using the simpler metabolic syndrome score. Results: The means of the metabolic syndrome measures differed between men and women. Nevertheless, as the degree of variance explained and the PC1 coefficients were remarkably similar, we used a common metabolic syndrome score. The metabolic syndrome score explained 50% of the variance of the metabolic syndrome measures, and waist circumference had the highest correlation (0.59) with this score. Each standard deviation increase in the metabolic syndrome score was associated with a markedly increased age-adjusted risk of developing diabetes (odds ratios: men 3.4 [95% CI 2.6-4.4]; women 5.1 [3.6-7.2]) and with increased incident CVD of 1.7 (1.4-2.1) in men and 1.7 (1.0-2.7) in women. Conclusions/interpretation: Our results, which should be confirmed in other populations, suggest that it is possible to evaluate the risk of the metabolic syndrome in a pragmatic fashion with a continuous score, obtained from principal components analysis of the basic, continuous syndrome measures.
引用
收藏
页码:1528 / 1535
页数:8
相关论文
共 28 条
[1]
The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
[3]
The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome.: The French DESIR study [J].
Balkau, B ;
Vernay, M ;
Mhamdi, L ;
Novak, M ;
Arondel, D ;
Vol, S ;
Tichet, J ;
Eschwège, E .
DIABETES & METABOLISM, 2003, 29 (05) :526-532
[4]
Balkau B, 1999, DIABETIC MED, V16, P442
[6]
INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[7]
Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study [J].
Dekker, JM ;
Girman, C ;
Rhodes, T ;
Nijpels, G ;
Stehouwer, CDA ;
Bouter, LM ;
Heine, RJ .
CIRCULATION, 2005, 112 (05) :666-673
[8]
Metabolic syndrome - Risk factor distribution and 18-year mortality in the multiple risk factor intervention trial [J].
Eberly, LE ;
Prineas, R ;
Cohen, JD ;
Vazquez, G ;
Zhi, X ;
Neaton, JD ;
Kuller, LH .
DIABETES CARE, 2006, 29 (01) :123-130
[9]
*EXP PAN DET EV TR, 2001, JAMA-J AM MED ASSOC, V285, P24868
[10]
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].
Ford, ES .
DIABETES CARE, 2005, 28 (07) :1769-1778